• Health

    Hims & Hers falls 8% as FDA issues warning letter over compounded weight loss drug

    AnyFans Posted on

    Hims & Hers falls 8% as FDA issues warning letter over compounded weight loss drug

    Sep. 16, 2025 11:14 AM ETHims & Hers Health, Inc. (HIMS) StockNVO, LLYBy: Jonathan Block, SA News Editor
    Comments
    The U.S. FDA has issued a warning letter to Hims & Hers Health (NYSE:HIMS) over its marketing of compounded semaglutide, the weight loss drug marketed under the brand name Wegovy by Novo Nordisk (NVO).
    Shares of Hims & Hers are
    Recommended For You
    More Trending News
    About HIMS Stock
    SymbolLast Price% Chg
    1D
    5D
    1M
    6M
    1Y
    5Y
    10Y
    Market Cap
    PE
    Yield
    Rev Growth (YoY)
    Short Interest
    Prev. Close
    Related Stocks
    SymbolLast Price% ChgHIMS–Hims & Hers Health, Inc.
    Trending Analysis
    Trending News

    You Might Also Like